Includes 6 months' free ExamPrepConnect Digital Access with print purchase!Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive print + digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions, detailed rationales, and a convenient print + digital package, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time!
Aligns with the latest ABIM Medical Oncology Certification Exam blueprint
Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors
Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam
Revised to include new treatment recommendations and FDA approvals
Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout
Content available digitally via ExamPrepConnect for study on the go
All the high-quality content from the book
Personalized study plan based on initial certification or MOC exam date
Ability to study by topic area to identify strengths and weaknesses
Timed practice test that simulates the test-taking environment
Discussion board to connect with Medical Oncology exam-prep community
See access details inside the book.